Sorin Group and Orange Develop Remote Monitoring Solution

The new solution is based on the ability of the Sorin Group (Milan, Italy) implanted CRM devices ability to send data to a noninvasive monitoring system located at the patient's home, and on the Orange Business Services (Paris, France) capabilities to manage the transmission of the data to the physician. Intelligent discrimination algorithms and data embedded into Sorin Group pacemakers, defibrillators, and cardiac resynchronization devices (CRDs) provide caregivers with specific information regarding the device behavior and the patient's condition. Using these data, physicians can detect arrhythmia or cardiac disease progression and provide timely therapy, which may reduce the need for hospitalization and improve the patients' quality of life. These diagnostic capabilities enable transmission of valuable alert messages, providing clinicians with relevant information and offering patients more peace of mind.

"Our strategy is to work with acknowledged leaders in other industries. We are delighted to have signed this collaborative agreement with Orange Business Services, a leading global integrated operator providing pioneering telecommunications services on a worldwide basis," said Stefano Di Lullo, president of the CRM business unit of Sorin Group. "This agreement demonstrates Sorin Group's commitment to continuously enhance the standards of care we deliver to patients and medical professionals."

"We are pleased to work with a leading company in the cardiovascular medical device industry in order to improve the efficiency and quality of physician-patient relationships," said Thierry Zylberberg, head of Orange Healthcare. "Sorin Group's advanced medical technologies and innovative therapeutic solutions, combined with Orange's expertise in application and program management for large, complex projects, will result in a solution that increases options to raise the quality of healthcare."

Patients with CRM devices require regular checkups with their physicians to ensure their devices are functioning properly and that the appropriate therapy is being delivered. However, managing a growing number of patients implanted with CRM devices, as well as the related follow-up, is increasingly demanding for many clinicians.

Related Links:
The Sorin Group
Orange Business Services